- Home
- EXAS vs UGI Comparison
EXAS vs UGI Comparison
Compare EXAS & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- UGI
- Stock Information
- Founded
- EXAS 1995
- UGI 1940
- Country
- EXAS United States
- UGI United States
- Employees
- EXAS N/A
- UGI N/A
- Industry
- EXAS Medical Specialities
- UGI Natural Gas Distribution
- Sector
- EXAS Health Care
- UGI Utilities
- Exchange
- EXAS Nasdaq
- UGI Nasdaq
- Market Cap
- EXAS 9.1B
- UGI 7.8B
- IPO Year
- EXAS N/A
- UGI N/A
- Fundamental
- Price
- EXAS $45.60
- UGI $35.23
- Analyst Decision
- EXAS Strong Buy
- UGI Buy
- Analyst Count
- EXAS 22
- UGI 3
- Target Price
- EXAS $66.43
- UGI $31.33
- AVG Volume (30 Days)
- EXAS 3.9M
- UGI 1.7M
- Earning Date
- EXAS 08-06-2025
- UGI 08-06-2025
- Dividend Yield
- EXAS N/A
- UGI 4.26%
- EPS Growth
- EXAS N/A
- UGI N/A
- EPS
- EXAS N/A
- UGI 1.92
- Revenue
- EXAS $2,939,949,000.00
- UGI $7,332,000,000.00
- Revenue This Year
- EXAS $14.61
- UGI $6.56
- Revenue Next Year
- EXAS $12.71
- UGI $8.89
- P/E Ratio
- EXAS N/A
- UGI $18.39
- Revenue Growth
- EXAS 12.55
- UGI N/A
- 52 Week Low
- EXAS $38.81
- UGI $23.14
- 52 Week High
- EXAS $72.83
- UGI $37.43
- Technical
- Relative Strength Index (RSI)
- EXAS 44.47
- UGI 43.85
- Support Level
- EXAS $40.55
- UGI $34.77
- Resistance Level
- EXAS $45.45
- UGI $35.96
- Average True Range (ATR)
- EXAS 2.04
- UGI 0.75
- MACD
- EXAS 0.07
- UGI -0.08
- Stochastic Oscillator
- EXAS 63.10
- UGI 40.34
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.